1. Home
  2. HALO vs DLB Comparison

HALO vs DLB Comparison

Compare HALO & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$67.12

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Logo Dolby Laboratories

DLB

Dolby Laboratories

HOLD

Current Price

$66.47

Market Cap

6.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
DLB
Founded
1998
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.4B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
HALO
DLB
Price
$67.12
$66.47
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$73.33
$93.60
AVG Volume (30 Days)
2.6M
657.1K
Earning Date
11-03-2025
01-28-2026
Dividend Yield
N/A
2.17%
EPS Growth
56.68
N/A
EPS
4.74
2.62
Revenue
$1,242,852,000.00
$1,349,130,000.00
Revenue This Year
$34.83
$5.03
Revenue Next Year
$24.84
$4.02
P/E Ratio
$14.22
$25.29
Revenue Growth
31.19
5.92
52 Week Low
$46.26
$64.02
52 Week High
$79.50
$89.66

Technical Indicators

Market Signals
Indicator
HALO
DLB
Relative Strength Index (RSI) 54.13 46.04
Support Level $61.23 $65.96
Resistance Level $66.60 $67.60
Average True Range (ATR) 2.03 1.21
MACD 0.28 -0.02
Stochastic Oscillator 81.90 16.33

Price Performance

Historical Comparison
HALO
DLB

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About DLB Dolby Laboratories

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

Share on Social Networks: